Investor's Business Daily on MSN
Alkermes shows improved relative strength; still shy of benchmark
A Relative Strength Rating upgrade for Alkermes shows improving technical performance. Will it continue?
Biotech has reasserted itself over the past year as drug approvals, obesity and GLP-1 programs, oncology pipelines, and ...
Investors in Alkermes plc ALKS need to pay close attention to the stock based on moves in the options market lately. That is ...
Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Tuesday, May 5, 2026 to discuss the company’s first quarter financial results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results